版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Chapter26GastrointestinalDrugsDigestivesystemanddiseasesDigestivesystem:
includeesophago,stomach,bowel,liver,courage
andpancreas
etc.Diseasesofdigestivesystem
Commoninclinic,diseasesofisotropyand
functionalityinthisorgans.Antacids
anddrugsusedtotreatpepticulcerdisease
Digestants
LaxativesandantidiarrhealdrugsAntiemetic
drugsAdjuvantdrugusedinliverandgalldiseases--Gallstone-dissolutingdrug
andcholereticdrug
--Drugusedtotreathepaticcoma
ClassificationofdrugsindigestivesystemSection1
Antacids
anddrugusedtotreatpepticulcerdisease
PathogenesisofpepticulcerExcessivesecretionofgastricacidandpepsin(2)InfectionofHelicobacterPylori(幽门螺旋杆菌,HP)(3)Mucosalprotectiveeffectdecreasing
--
gastromucosalfluid(胃粘液)andHCO3—secretion
--prostaglandins(PGs)Drugsusedtotreatpepticulcerdisease1.Gastricacidantisecretorydrugs2.Antacids3.Mucosalprotectiveagents4.Anti-Hpagents1.
GastricacidantisecretorydrugsAcetylcholineHistaminePGE2andPGI2Gastrin
H+、K+-ATPaseGastricacidsecretionbyparietalcellsGastricacidsecretion--acomplexandcontinuousprocess,factorsasfollows:nerve(ACh)---M3-Rparacrine(histamine)---H2-RH+-K+-ATPaseendocrine(gastrin)---CCK2-R
ThereareAChandgastrinreceptorsinenterochromaffin-likecell(肠嗜铬样细胞,ECL).AChandgastrincannotonlystimulateparietalcellsdirectlybutalsoenhancehistaminereleaseandstimulategastricacidsecretionindirectly.----H2-RantagonistcaninhibitgastricacidsecretioninducednotonlybyhistaminebutalsoACh
andgastrin.parietalcells
Protonpumpinhibitors
Omeprazole(奥美拉唑),Lansoprazole(兰索拉唑),Rabeprazole(雷贝拉唑),Pantoprazole(泮托拉唑),
Esomeprazole(埃索美拉唑).
(1)InhibitorsofH+/K+-ATPase--
InhibitorsofH+/K+-ATPaseorprotonpump,reducegastricacidsecretion
Omeprazole(奥美拉唑,洛赛克,losec)---Changetocompetentsulphonamide
(次磺酰胺)inacidenvironment.TheScombinewiththe–SHofH+/K+-ATPase,H+pumpwasinactivated,andthesecretionofgastricacidwasdecreased
--Increasegastricmucosalbloodflow--inhibitHPpepticulcer:Gastrelcosisandduodenalulcer.(superiortoH2-Rantagonists)Refluxesophagitis(gastroesophagealrefluxdisease,GERD胃食管反流病)Zollinger-Ellisonsyndrome卓-艾综合症----inducedbytumorofGastricAntrum(胃窦)Gcellwhichsecretegastrin;---Characteristic:Hypergastrinemia,generousgastricacidsecretion,multipleandrefractoryupperdigestivetractpepticulcer.
ClinicalusesClinicalusesUppergastrointestinalbleeding:pH7.0,easilystopbleedEradicateHP:combinedwithantibioticsClarithromycin克拉霉素,amoxicillin阿莫西林GastrinomaandgastrelcosisinducedbyNSAID.parietalcells
Mechanism:
blockH2-R→reducethesecretionofgastricacid→↓thevolumeofgastricacid&acidityClinicaluses:
①pepticulcer②zollinger-ellisonsyndrome(卓-艾综合征)③gastroesophagealreflux(胃食管反流)(2)H2-receptorantagonists
Adversereaction:
1)Antiandrogeniceffect:gynecomastia(男子女性型乳房),
impotency,galactorrhea
(溢乳)2)Inhibitliverinducedenzyme:inhibitorsofdrug-metabolizingenzymesInhibitcytochromeP450catalyzedoxidativedrugmetabolismpathway→reduceclearanceofotherdrugsCimetidine(西咪替丁;甲氰咪胍):
400mgbid4W→80%healingRanitidine(雷尼替丁)1)Antisecretiveeffectis10timesthatofCimetidine.2)Lesseffectonhepaticmicrosomalmetabolismsystem.3)LongerdurationandlessantiandrogeniceffectFamotidine(法莫替丁),Nizatidine(尼扎替丁):1)Antisecretiveeffectis30times
thatofCimetidine.2)Havenoeffect
onhepaticmicrosomalmetabolismsystem.Ebrotidine(乙溴替丁):1)↑Expressionofepidermalgrowthfactor(EGF,表皮生长因子)andplatelet-derivedgrowthfactor(PDGF,血小板衍生生长因子)→stimulateproliferationofepithelium2)increasemucussecretion
(2)M1-receptor
antagonistsBlock
M1-receptor
selectively,Inhibitgastricacidsecretion
UsedingastrelcosisandduodenalulcerPirenzepine(哌仑西平)Telenzepine
(替仑西平)BlockGastrinreceptor
InhibitH+pumpReducegastricacidsecretionProtectgastricmucosa
(4)G-receptor
antagonistsProglumide丙谷胺Similarstructurewithgastrin,combinecompetitivelyG-receptorwithgastrinGastrelcosisandduodenalulcerAcuteuppergastrointestinalhemorrhage
Clinicalusage2.Antacids
Weakbases
:Mg(OH)2,MgSiO3,Al(OH)3CaCO3,Ca(HCO3)2,NaHCO3Actions:
1)neutralizegastricacid→reducegastricacidity→reducepepticactivity2)injuryfromH+2.
AntacidsPepticulcerGastroxia(胃酸过多症)TherapeuticUsesCompoundpreparation(复方制剂)
isusedoften.
3.MucosalProtectiveAgents
Cellbarrier
GastricmucosalbarriercytomembranetightjunctionresistgastricacidandpepsinReconstructionandregenerationMucosalfluid-HCO3-GlucoproteinandbicarbonatePGs(PGE2、PGI2)
--StimulatePG-receptor,inhibitcAMPdependentcalciumchannel
andH+pump,reducethegastricacidsecretion;PGE2PGI2--Enhancethesecretionofmucosalfluidandbicarbonateby
stomachandduodenalsecretion
--Increasegastricmucosalbloodflow--Protectgastricmucosa--Stimulatereceptor,inhibitthesecretionofgastricacidandpepsin
causedbygastricacid,histamine,gastrin,andfood--Inhibitgastricbleeding,ulcerandnecrosis
causedbyacetylsalicylicacidetc.
Misoprostol米索前列醇
increasethesecretionofgastricmucosalfluidandHCO3—,regionalbloodflowClinicaluses--Gastrelcosisandduodenalulcer--GastrointestinalhemorrhageMechanismsofActionSucralfate
(硫糖铝)--formingcomplexgelwithmucus,createsaphysicalbarrierthatimpairsdiffusionofHClandpreventsdegradationofmucusbypepsin--adsorb
pepsinandcholalicacid,inhibitactivity--increasethe
secretionofgastricmucosalfluidand
HCO3—
GastrelcosisandduodenalulcerBismuthpotassiumcitrate(枸橼酸铋钾)Protectsgastricmucosa
IncresesPGEreleaseInhibitsHelicobacterpyloriInactivatepepsinMechanismofaction:
1)selectivebindingtoulcer,coatingitandprotectingitfromacidandpepsin.2)inhibitpepsinactivity3)stimulatemucousproduction4)increaseprostaglandinsynthesis.5)antimicrobialactivityagainstHpylori
Gastrelcosisandduodenalulcerwhencombinedwithantibiotics(metronidazole甲硝唑andtetracycline四环素),ulcerhealingratesofupto98%havebeenseen.clinicalusesColloidalBismuthSubcitrateranitidine枸橼酸铋钾雷尼替丁BismuthPotassiumCitrateranitidineDouble-acting4.Anti-HpagentsHelicobacterpylori(Hp)Agents-Metronidazole甲硝唑-Tetracycline四环素-Ampicillin氨苄西林-Amoxicillin阿莫西林2005年诺贝尔奖澳大利亚临床微生物学家RobinWarren和BarryMarshallSection2Digestants
Dilutehydrochloricacid
PepsinPancreatinDriedyeastBiofermin(乳酶生,lactasin)Compositionofdigestivejuice
AgentsthatenhanceitssecretionSection3
LaxativesandAntidiarrhealDrugs-Increasewater-Softfeces-Promoteenterokinesia-Helpdefecation
Bulklaxative
容积性泻药Contactcathartics
接触性泻药Emollientcathartics
润滑性泻药1.
LaxativesBulkLaxative
Magnesiumsulfate
-increasethebulk-increasecholecystokinin(胆囊素)secretion-cholagogueaction(利胆作用)口服后肠道很少吸收,在肠腔内形成高渗,增加肠容积而促进肠道推进性蠕动,产生泻下作用。Whatisthebulklaxative?SodiumsulfateClinicaluses:obstructivejaundicechroniccholecystitis(慢性胆囊炎)ContactcatharticsPhenolphthalein(酚酞)Anthraquinone(蒽醌)Castoroil(蓖麻油)与肠粘膜接触,改变肠粘膜的通透性,使电解质和水分向肠腔扩散,使肠腔水分增加,蠕动增强,引起泻下。WhatistheContactcatharticsEmollientcathartics
liquidparaffin(液体石蜡)Glycerin(甘油)2.AntidiarrhealDrugs-Diphenoxylate(地芬诺酯)-medicinalactivatedcharcoal
(活性炭)--absorption-Opiumpreparations-Albumintannate(鞣酸蛋白)--stypsis常见症状,可引起疼痛,对毒物的排出有一定保护作用。但严重的腹泻,可引起脱水和电解质紊乱,应适当给予止泻药以缓解症状。能使胃粘膜表面蛋白质凝固、沉淀,从而减轻刺激,降低炎性渗出物,发挥收敛、止泻作用。DiarrheaSection4Antiemetic
DrugsVestibularfunctionCTZ(chemoreceptortriggerzone)D2,H1,M1,5-HT3
Whydoseapersonvomite?Scopolamine东莨菪碱Benzhydramine苯海拉明Chlorpromazine氯丙嗪Dimenhydrinate乘晕宁Ondansetron
(昂丹司琼)
:usedinthepreventionofchemotherapy-inducedandpostoperativenauseaandvomiting1.5-HT3-Rinhibitor2.dopaminereceptorantagonists:Metoclopramide(甲氧氯普胺)
Mechanism
1)blockD2-receptorinCTZ2)blockgastrointestinalD-receptor→promotevermiculation肠蠕动
Clinicaluses:
1).Vomiting-Functionaldisorderofgastrointestinaltract-Radiotherapy,operationand
drugs
2)Gastrointestinaltract
hypotonia张力减退Adversereaction:
extrapyramidal(锥体束外的)symptoms,especiallydystonia(张力障碍)--blockDA-receptorofgastrointestinalmuscularlayer
nerveplexus,promotevermiculation(肠蠕动)--de pressthepostsynapse
cholinergicneurondepressanteffect,increaseAChrelease.--difficultlypenetrateBBB,havenoextrapyramidalsymptomsDomperidone(多潘立酮,吗丁啉)Gastrointestinalprokinetics
Nausea,vomiting-hemicrania偏头痛-craniocerebraltrauma颅脑损伤-radiationtherapy
GastrointestinaldyskinesiaClinicalUsesCisapride(西沙比利)
stimulate5-HT4-R,
promoteAChreleaseOthers1.
H1receptorblocker:Diphenhydramine苯海拉明,Dimenhydrinate乘晕宁2.Mreceptorblocker:
Scopolamine东莨菪碱3.D2
receptorblockerinCTZChlorpromazine氯丙嗪Section5
Gallstone-dissolutingdrug
andcholereticdrug
Ursodeoxycholicacid(熊去氧胆酸)1.
Lowerthecontentof
cholesterolinbile,
makecholesterol
dissolve
fromthe
surfaceofcalculus.2.
inhibittheabsorptionofcholesterolinintestinaltract3.
Usedin
cholesterolc
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024施工混凝土合同范本
- 2024年中英文对照技术文档制作与审核合同3篇
- 2024年高端住宅销售代理协议版
- 2025年度甜品连锁店品牌授权合作合同范本3篇
- 2024幼儿园幼儿安全与健康管理聘用协议书3篇
- 2024幼儿园教师学生个性发展与教育引导合同3篇
- 2024年电子商务用户隐私保护协议3篇
- 2024年电子产品物流配送合同
- 2025年度冷链仓储与配送服务合同范本3篇
- 2024物流运输合同涉及的责任与义务
- GB∕T 41627-2022 动物源空肠弯曲菌检测方法
- 供货保障措施
- (完整版)常用乐高零件清单汇总
- 消防四个能力
- 机动车环检标准方法验证模板
- AQL标准抽样检验表
- 美国Control4智能家居设计方案解说资料
- DES算法Matlab代码
- 交通事故快速处理单(正反打印)
- 电缆热稳定校验计算书
- 2020国际大专辩论赛顺境或逆境更有利于人的成长
评论
0/150
提交评论